Crossmark

Chromatographic assay of recently approved co-formulation of Vonoprazan fumarate with low dose Aspirin: AGREE, Complex MoGAPI, and RGB 12-model assessments

Crossref DOI link: https://doi.org/10.1186/s13065-024-01344-7

Published Online: 2024-11-16

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Moneim, Mona M. Abdel

Hamdy, Mohamed M. A.
Funding

Funding for this research was provided by:

Pharos University
License Information

Text and Data Mining valid from 2024-11-16

Version of Record valid from 2024-11-16
More Information

Article History

Received: 15 April 2024

Accepted: 4 November 2024

First Online: 16 November 2024

Declarations

:

: Not applicable.

: Not Applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below